layoffs
-
Blood Biotech Grifols Cuts Deep in the U.S. to Find €400M in Savings
Grifols said the layoffs sparked by its restructuring represent just 8% of its workforce. But the cuts will happen mainly in the Barcelona-based company’s U.S. plasma operations, source of most of the plasma that is the basis for its biologic medicines.
-
Healthcare Moves: A Monthly Summary of Hires and Layoffs
Here is a selection of recent executive hires, departures and layoffs occurring across the healthcare industry.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Introducing MedCity Moves, a New Podcast on Healthcare’s Corporate Ladder
MedCity News is launching a new podcast called MedCity Moves focusing on healthcare’s corporate ladder. Published monthly, episodes will provide a summary of notable executive appointments and layoff news — as well as an interview with a recently-appointed healthcare leader or anyone that is experiencing a shift in their job.
-
Rubius’s New Cell Therapy Strategy Runs Out of Time & Money; Workforce Is Cut by 82%
Rubius Therapeutics was unable to secure financing to carry out its pivot to a new manufacturing process for its red blood cell-based cell therapies. The once high-flying biotech is now exploring options that could include a sale of the business or a merger with another company.
-
Microbiome biotech Kaleido Biosciences shutters amid cash crunch, drug setbacks
Kaleido Biosciences, formed by Flagship Pioneering as part of a wave of biotech companies developing microbiome therapies, has laid off its entire workforce and is winding down operations. The shutdown follows a strategic review that failed to turn up any deals to support its clinical-stage pipeline.
-
Zosano Pharma cuts staff 31%, the latest layoffs in a wave of biotech belt-tightening
Regulatory setbacks for a new migraine treatment have led Zosano Pharma to restructure, laying off about 31% of its staff. Zosano is one of several biotechs that announced cost-saving measures this week.
-
Cash woes at neuro biotech Yumanity lead to 60% staff cut and search for a buyer
Yumanity’s corporate restructuring means the biotech is now exploring “strategic alternatives” that could include a sale of the company or its assets. The biotech’s lead drug candidate is an experimental Parkinson’s disease drug currently in Phase 1 testing.
-
After Phase 3 failure busts blockbuster bid, Deciphera restructures; staff slashed 35%
Deciphera Pharmaceuticals’ corporate restructuring will slash headcount by 35% and stop work on two drug programs. Going forward, the biotech said it will focus on developing drugs that have the potential to be the first or the best in their therapeutic classes.
-
Survey: Nearly half of medical practices have furloughed workers
A survey by MGMA revealed that 48% of medical practices have experienced furloughs, and 22% have experienced layoffs as a result of Covid-19. Those numbers are expected to increase in May if conditions continue for the next month.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
Faced with slowing demand, 23andMe cuts 100 employees
The DNA testing company confirmed on Thursday that it would lay off about 100 employees. The restructuring was a result of slowing consumer demand.
-
Athenahealth lays off employees after sale to Veritas Capital and Elliott Management
A source familiar with the situation told MedCity that less than 4 percent of the company’s total corporate workforce across all offices was let go.
-
IBM confirms layoffs impacted its Watson Health division
Spokesman Doug Shelton verified that IBM’s recent round of layoffs hit its Watson Health unit, but he did not specify how many individuals lost their jobs, according to The Herald Sun.
-
Peter Thiel-backed carrier screening upstart Counsyl lays off 27 employees
Counsyl’s layoffs are in sales support, marketing, design and engineering.
-
Devices & Diagnostics, Hospitals
Caught in a bind, some its own doing, some not, St. Jude Medical cuts another 500 workers
What do you do when the biggest market you play in continues to be weak, […]
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
